Recruiting

Observational Study

Sponsor:

Brigham and Women's Hospital

Code:

NCT05155813

Conditions

Sleep Apnea

Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

WatchPAT

Study Details

Brief summary:

The investigators will screen consecutive patients presenting to the atrial fibrillation clinic for sleep apnea using a FDA-approved home sleep testing device, WatchPAT to determine prevalence of sleep apnea in a clinic-based sample.

Conditions

Sleep Apnea

Atrial Fibrillation

Study ID

NCT05155813

Start date

Feb 1, 2022

Status verified date

Jun, 2022

Completion date

Dec 31, 2023

Anticipated

Primary completion date

Dec 31, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of AF confirmed on any electrocardiographic recording
  • Age greater than or equal to 18
  • Ability to read and understand consent form, complete questionnaires, and provide informed consent

Exclusion Criteria:

  • Prior diagnosis of sleep disordered breathing or negative testing within the past 2 years without significant change in weight or clinical symptoms of sleep apnea
  • History of Raynaud

Study Design

Enrollment

300 participants

Anticipated

Interventions and Outcome Measures

Interventions

WatchPAT

FDA-approved portable home sleep testing device worn on the wrist.

Primary outcome measure

  • Prevalence of sleep apnea [ Time Frame: 2 year study ]

Central Contacts and Locations

Central contacts

Sogol Javaheri, MD

617-983-7280sjavaheri@bwh.harvard.edu

Elliott Antman, MD

eantman@rics.bwh.harvard.edu

Locations

Brigham and Women's Hospital

Recruiting

Boston, Massachusetts, United States, 02215

Contacts

Sogol Javaheri, MD

617-983-7288sjavaheri@partners.org

More Information

Sponsor

Brigham and Women's Hospital

Last update posted

Jun 7, 2022

Last verified

Jun, 2022

Keywords

  • sleep apnea
  • atrial fibrillation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2022-06-07.